Caduet

This page contains recent news articles, when available, and an overview of Caduet but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Abbott Labs' Deal with Teva Pharma Is 'Phat News' for Lipid-Lowering Franchise  -  ‎Dec 14, 2009‎
...drug Caduet delivered $589 million in 2008 sales; Merck's dual lipid-lowering pill Vytorin has already generated $1.5 billion in global sales in 2009. ... BNET

Outsourcing steroid for Indian pharma firms  -  ‎Dec 20, 2009‎
...an innovator company) for products such as Valtrex, Aricept, Lipitor, Caduet, Nexium and Flomax in five years, estimated analysts with Morgan Stanley. ... Rediff

Generics Makers Line Up To Sell Copies Of Pfizer's Lipitor  -  ‎Nov 6, 2009‎
Separately, Pfizer said Novartis AG's (NVS) Sandoz unit has filed for FDA approval of a generic version of Pfizer's Caduet, which combines Lipitor with ... CNNMoney.com

Pfizer's Handa is new MD of Wyeth India  -  ‎Oct 26, 2009‎
...on an income of Rs 1019.76 crore for FY 07. Pfizer has launched five patented products in India since 2005 — Vfend, Viagra, Lyrica, Caduet and Macugen. Financial Express

Island Girl: 'Somehow my husband has ended up in jail'  -  ‎Oct 21, 2009‎
The jailer assured J that a medic would visit his cell within the hour to re-check his BP and give him a dose of Caduet. Neither of these things happened. ... Crosscut

REG-Pfizer Inc Pfizer Reports Third-Quarter 2009 Results  -  ‎Oct 20, 2009‎
1379 1567 (12 ) 1474 1575 (6 ) NORVASC 488 562 (13 ) 14 22 (34 ) 474 540 (12 ) CHANTIX / CHAMPIX 155 182 (15 ) 75 96 (22 ) 80 86 (7 ) CADUET 130 148 (12 ... Reuters

Court Report  -  ‎Oct 25, 2009‎
1997) based on Sandoz's filing of an ANDA to manufacture a generic version of Pfizer's Caduet® (atorvastatin calcium -- the active ingredient in ... Patent Docs (blog)

Drug stocks mixed; Pfizer climbs on Lipitor deal  -  Jun 18, 2008
Caduet is a combination of Lipitor and Pfizer's Norvasc, which lost patent protection in 2007. Lipitor patents will begin expiring in 2010. ... MarketWatch

Nigeria: Minister of Health, Others Endorse Pfizer's Caduet  -  Aug 3, 2006
Lagos — Minister of Health, Prof. Eyitayo Lambo, DG, National Agency For Food and Drugs Administration And Control (NAFDAC), Prof. Dora Akunyili, Asagba of ... AllAfrica.com

After Viagra, Indians may pop Caduet: Rediff.com news  -  Dec 23, 2005
After Viagra, Pfizer [ Get Quote ] is planning bringing another of its blockbuster drugs to India. Caduet, a new generation cardiovascular drug, ... Rediff

Casual Male reports 85% lower profit in 4th quarter  -  Mar 26, 2008
Caduet, which had $568 million in 2007 sales, combines Lipitor with Pfizer's Norvasc, a drug used to treat high blood pressure. (Bloomberg) ... Boston Globe

Pfizer Sues Ranbaxy to Block Generic Form of Caduet  -  Mar 12, 2007
By Susan Decker. March 12 (Bloomberg) -- Pfizer Inc., the world's biggest drugmaker, sued Ranbaxy Laboratories Ltd. to block a generic version of the ... Bloomberg

A Pfizer Scientist Sees Research Dividends Ahead  -  Jul 18, 2006
Between 2000 and 2005, Pfizer's laboratories created only a handful of new drugs, leaving the company dependent on dubious innovations like Caduet, ... New York Times

Article: Combo pills perk up firms' profits: Treating 2 ills avoids...  -  Feb 19, 2007
With Caduet, physicians now have ... treatment with Lipitor and Norvasc is ... Caduet and Lipitor are contraindicated ... The side effects of Caduet are ... Pay-Per-View - Chicago Tribune - HighBeam Research

Pfizer fills its dry pipeline with optimism - Business - International...  -  Jul 17, 2006
Between 2000 and 2005, Pfizer's laboratories created only a handful of new drugs, leaving the company dependent on dubious innovations like Caduet, ... New York Times

Pfizer Trims Guidance  -  Apr 20, 2007
The impotence drug Viagra gained 11% to $434 million; the schizophrenia drug Geodon advanced 18% to $216 million; and Caduet, which combines Lipitor and ... TheStreet.com - TheStreet.com (subscription)

Pfizer, Ranbaxy at it again over Caduet  -  Mar 14, 2007
New Delhi, Mar 13: Ranbaxy Laboratories on Tuesday stood firm on its strategy of challenging patents, even as Pfizer has filed a suit against it to block ... Financial Express

… Programme Results Show That a New Therapy, Caduet(R), can Optimise...  -  Jun 13, 2006
Results from the JEWEL programme show that single-pill amlodipine/atorvastatin therapy, also known as Caduet, is an effective treatment that simultaneously ... ots.at

Caduet.(drug overview)(Drug overview)  -  Dec 1, 2005
Caduet is a combination of two drugs, amlodipine (also known as Norvasc) and atorvastatin (also known as Lipitor). It's used for people who need both ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com

Pfizer Inc wins case blocking Ranbaxy's generic drug Caduet  -  Dec 2, 2007
Dec 1Pfizer Inc, the world's biggest drugmaker, won a US court ruling that bars India's Ranbaxy Laboratories Ltd from selling a generic version of the blood ... Financial Express

Pfizer Q2 net soars 132 pc on plant sale  -  Jun 29, 2006
...(to treat nerve-pain) and Caduet (for blood-pressure and high-cholestrol), Pfizer's Managing Director in India, Mr Kewal Handa, told Business Line. ... Hindu Business Line

Single pills pack a multiple punch; A new crop of combination …  -  Apr 30, 2007
For example, the patent for Norvasc, one of the two drugs in Caduet, ... He found that patients taking such combinations as Caduet and Vytorin (which ... Pay-Per-View - Los Angeles Times - ProQuest Archiver

ASCOT Trial - Amlodipine Reduces Cardiovascular Mortality  -  Sep 8, 2005
Caduet is a prescription drug that combines 2 medicines, Norvasc® (amlodipine ... Caduet is not for everyone. It is not for those with liver problems. ... RxPG NEWS

Adding Lipitor Early to Effective Blood Pressure Treatment Provided a...  -  Jan 16, 2008
Caduet is a prescription drug that combines 2 medicines, Norvasc and Lipitor. ... Caduet is not for everyone. It is not for those with liver problems. ... RedOrbit

Caduet (Amlodipine Besylate/Atorvastatin calcium), First Pill to...  -  Feb 14, 2006
KIRKLAND, QC, CANADA -- February 14, 2006 -- Pfizer Canada Inc. announced today that Caduetâ„¢ (amlodipine besylate and atorvastatin calcium), ... DG News

Article: New indication for Caduet.(Products)(Brief Article) - Family...  -  May 1, 2005
New indication for Caduet.(Products)(Brief Article) ... find Family Practice News articles. The combination drug Caduet (amlodipine besylate/atorvastatin ... Pay-Per-View - Family Practice News - HighBeam Research

One step forward, another back  -  Apr 15, 2008
...and two more cases have been filed in the US to protect Lipitor and Caduet. As these cases progress to superior courts, the stakes will only get higher. ... Express Pharma

Pfizer Wins Caduet Patent Suit Against Ranbaxy  -  Dec 11, 2007
A federal judge has ruled in favor of Pfizer in a patent infringement suit involving Ranbaxy Laboratories and Pfizer's patents covering Caduet. ... FDA news - FDA news (subscription)

Express Scripts to push generic prescriptions next year  -  Oct 5, 2005
Other Pfizer drugs the company is taking off of the formulary include Norvasc, Caduet, Viagra and Detrol/LA, reports said. ... St. Louis Business Journal

ASH: Combo Pill Reins in Blood Pressure and Lipids in African …  -  May 22, 2006
NEW YORK, May 22 — Almost half of African Americans treated with Caduet, ... Patients received one of eight dosage strengths of Caduet ranging from low dose ... MedPage Today

QualityStocks.net News – Pfizer Inc. (PFE) Announces 70  -  Apr 8, 2008
The company is widely known for Lipitor, its cholesterol combatant; Caduet, for cardiovascular issues; Aricept, for Alzheimer's disease; Zoloft for various ... TransWorldNews - TransWorldNews (press release)

down to earth, online  -  Apr 30, 2007
The Ranbaxy-Pfizer dispute involves three drugs:Lipitor, Caduet and Norvasc. ... The combination drug, Caduet is the third item in the picture. ... Down to Earth - Down to Earth (subscription)

… Programme Results Show That a New Therapy, Caduet(R), can Optimise...  -  Jun 13, 2006
JEWEL Programme Results Show That a New Therapy, Caduet(R), can Optimise Treatment for Patients With Hypertension and Additional Cardiovascular (CV) Risk ... Pay-Per-View - PR Newswire - HighBeam Research

Hostile bids  -  Oct 22, 2007
My portfolio -- which includes Aricept, Caduet, Celebrex, Exubera, Lipitor, Norvasc, Relpax, Viagra, Zoloft and Zyrtec -- features many of the world's ... $2.95 - Lexington Herald Leader - NewsBank

… Programme Results Show That a New Therapy, Caduet(R), can Optimise...  -  Jun 13, 2006
JEWEL Programme Results Show That a New Therapy, Caduet(R), can Optimise Treatment for Patients With Hypertension and Additional Cardiovascular (CV) Risk ... Pay-Per-View - PR Newswire Europe - HighBeam Research

Press Release: /FIRST ADD -- NYTU041B -- Pfizer Inc Earnings/. - PR …  -  Apr 19, 2005
Q2) How is Caduet performing? A2) Worldwide sales of Caduet totaled $31 million in ... The market performance of Caduet in the U.S. continues to improve. ... Pay-Per-View - PR Newswire - HighBeam Research

Combo pills perk up firms' profits: Treating 2 ills avoids expiring...  -  Feb 19, 2007
Pfizer last month reported that 2006 sales doubled for its Caduet, ... Pfizer said its studies have shown that patients taking Caduet are more compliant ... Free with registration - Chicago Tribune - AccessMyLibrary.com

Analysis: Combo First for Blood Pressure  -  May 20, 2006
Overall, using the Caduet regimen, 48.3 percent of patients was able to reach their goals of controlling blood pressure and controlling cholesterol. ... RedOrbit

/FIRST ADD -- NYTU041B -- Pfizer Inc Earnings/.  -  Apr 19, 2005
Q2) How is Caduet performing? A2) Worldwide sales of Caduet totaled $31 million in the ... The market performance of Caduet in the US continues to improve. ... $4.95 - PR Newswire - ECNext

Pill cuts heart attack and stroke risk 'in half'  -  Oct 18, 2006
Patients taking the Pfizer drug Caduet (amlodipine besylate/atorvastatin ... Caduet combines two other drugs, Norvasc and Lipitor, which respectively treat ... Hays Pharma

Saving Money on Blood Pressure Meds  -  May 14, 2007
Using a model study, researchers found the single-tablet medication regimen, sold as Caduet, to be less expensive and just as effective, if not more so, ... Ivanhoe Broadcast News

Pfizer's Caduet reduces 10-yr CV risk by 54%.(cardiovascular)(Brief …  -  Oct 23, 2006
Pfizer's Caduet (amlodipine besylate and atorvastatin calcium) may reduce the 10-year risk of having a cardiovascular event 54% in hypertensive patients ... $4.95 - Pharma Marketletter - ECNext

Pfizer's Caduet reduces 10-yr CV risk by 54%.  -  Oct 23, 2006
Pfizer's Caduet reduces 10-yr CV risk by 54%. Pfizer's Caduet (amlodipine besylate and atorvastatin calcium) may reduce the 10-year risk of having a ... $9.94 - Pharma Marketletter - Alacra Store

/FIRST ADD -- NYW043A -- Pfizer Inc Fourth-Quarter 2004 Performance …  -  Jan 19, 2005
Q2) How is Caduet performing? A2) Worldwide sales of Caduet totaled $15 million in ... We believe that Caduet is on its way to becoming an extremely useful ... $4.95 - PR Newswire - ECNext

辉瑞制è?¯è¾¾æˆ?仿照Lipitorè?¯ç‰©å??è®®  -  Jun 19, 2008
...该公å?¸åœ¨å‘¨ä¸‰æ—©é—´å®£å¸ƒè¾¾æˆ?了上述å??议,称在Lipitorè?¯ç‰©çš„一项é‡?è¦?专利于2011å¹´11月到 期之å?Žï¼Œè¯¥å…¬å?¸å°†å…?许Ranbaxyå…¬å?¸åœ¨ç¾Žå›½å’Œå…¶ä»–7个国家销售Lipitor以å?ŠCaduetè?¯ç‰©çš„ ... 新浪网

Press Release: /FIRST ADD -- NYW043A -- Pfizer Inc Fourth-Quarter …  -  Jan 19, 2005
Q2) How is Caduet performing? A2) Worldwide sales of Caduet totaled $15 million in ... We believe that Caduet is on its way to becoming an extremely useful ... Pay-Per-View - PR Newswire - HighBeam Research

Caduet halves risk of cardiovascular events over 10 years: GEMINI...  -  Oct 30, 2006
Caduet from Pfizer Japan is a combination of amlodipine, the calcium blocker, and atorvastatin for the treatment of hyperlipidaemia. ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones

Economía/Empresas.- Almirall alcanza un acuerdo con Pfizer para …  -  Nov 11, 2008
La firma farmacéutica explicó que Pfizer también comercializará en España el fármaco, que combina amlodipino y atorvastatina, bajo la marca Caduet y precisó ... ADN.es

选é™?压è?¯ç®—算性价比  -  Oct 12, 2005
...高血压病人�使血脂�高,也应该�用�脂�,因此,�久�,辉瑞公�把�脂�立普 妥和�压�络活喜结��一�新�Caduet,并获得FDA的批准,已在欧美国家上市。 ... 光明网

Combo pills: Convenience vs. cost  -  Oct 20, 2008
Pfizer Inc's Caduet, a prescription pill that combines the blood pressure pill ... Because Caduet is often not on a health plan's preferred list of drugs, ... Pay-Per-View - Chicago Tribune - ProQuest Archiver

Ailing Pfizer looks for cure in India; Viagra is first step in drug...  -  Apr 24, 2006
In early March, the company rolled out Caduet, which treats high blood pressure, and Lyrica, a pain management drug that also treats symptoms of anxiety and ... $9.94 - Crain's New York Business - Alacra Store

辉瑞制è?¯å…¬å?¸äºŒå?ˆä¸€æ–°è?¯ï¼šCaduetæ—¥å‰?上市  -  Jul 27, 2005
...æ?®ç¾Žå›½åª’体报é?“,辉瑞制è?¯å…¬å?¸æ—¥å‰?把治疗高血压和治疗高胆固醇的两ç§?è?¯ç‰©åŠ å·¥æˆ?一ç§? 上市,å‡?少了高血压患者æœ?è?¯çš„ä¸?便。 辉瑞制è?¯å…¬å?¸çš„æ–°è?¯å??å?«â€œCaduetâ€?,它包å?«ä¸¤ç§? ... æ?œç‹?

高血脂加高血壓心血管拉警報  -  Mar 29, 2007
...考慮患者�藥順從度,藥廠研發�時治療血壓�血脂的複方新藥「脂脈優(Caduet)�, ��治療高血壓用藥脈優��血脂藥物立普妥,已�得��給付。 ... ��新�網

雙藥å?ˆä¸€è¡€å£“ã€?血脂兼治  -  Mar 28, 2007
...一項包括å?°ç?£ï¼ˆ104人)ã€?亞太ã€?中æ?±ã€?澳洲ã€?拉ä¸?美洲等國家ã€?1649å??血壓å?Šè¡€è„‚異常 患者的心血管疾病風險的跨國性研究發ç?¾ï¼Œæœ?用複方新藥Caduet(脂脈優)14周之後,六 ... è?¯å?ˆæ–°è?žç¶²

Single pill helps controls BP, cholesterol  -  Feb 19, 2008
The single pill combo is marketed as Caduet by Pfizer, the company that ... Caduet contains the drug amlodipine, used to treat high blood pressure and ... Reuters UK

Pfizer steps up launches from global portfolio.  -  Mar 3, 2006
Pfizer has also launched another of its blockbuster drugs, Caduet, in India. Caduet, a new generation cardiovascular drug, is a combination of atorvastatin ... Free with registration - Economic Times - AccessMyLibrary.com

Zachráni nám srdce  -  Feb 5, 2008
Unikátny prípravok, ktorý dostanete iba na lekársky predpis, sa volá Caduet. Za 10 mg škatuľku zaplatíte v lekárni 171,50 Sk, za 50 mg 205,40 Sk. ... Pluska.sk

Dual-Purpose Drugs May Promise Healthy Future For Pharmaceutical …  -  Jan 18, 2005
This was Pfizer's (nyse: PFE - news - people ) strategy for Caduet, which bonds its bestsellers ... "Everyone's watching to see how Caduet performs," says Shah. Forbes

Pfizer lance Caduet, un nouveau médicament avec des packagings …  -  Jun 5, 2007
Caduet est un nouveau médicament des laboratoires Pfizer qui associe deux molécules de référence, l'amlodipine et l'atorvastatine. Caduet est une innovation ... categorynet.com

Article: Pfizer steps up launches from global portfolio. - Economic...  -  Mar 3, 2006
Pfizer has also launched another of its blockbuster drugs, Caduet, in India. Caduet, a new generation cardiovascular drug, is a combination of atorvastatin ... Pay-Per-View - Economic Times - HighBeam Research

Siemens, GFI, EADS, Parmalat, Hoechst, Pfizer in Court News  -  Jun 19, 2008
Caduet, a Pfizer drug that combines Lipitor and the company's blood pressure medicine Norvasc, ... Caduet last year generated $568 million in global sales. ... Bloomberg

Patients Taking A Regimen Based On Pfizer's Norvasc Experienced …  -  Sep 4, 2005
Caduet is a prescription drug that combines 2 medicines, Norvasc(R) (amlodipine ... Caduet is not for everyone. It is not for those with liver problems. ... RedOrbit

CADUET® puede optimizar el tratamiento de pacientes con hipertensión ...  -  Jun 13, 2006
La terapia basada en la administración de Caduet, que combina amlodipino y atorvastatina en una única pastilla, es un tratamiento efectivo en la reducción ... acceso.com

PFIZER-RANBAXY LIPITOR DEAL NEEDS SCRUTINY  -  Jun 21, 2008
Moreover, the two firms also came to an understanding over Caduet. ... Regulators should ask whether Pfizer ponied up Caduet to keep Ranbaxy from goring its ... Livemint

=> Patients Taking a Regimen Based On Pfizer's Norvasc Experienced …  -  Apr 9, 2005
Caduet is a prescription drug that combines 2 medicines, Norvasc(R) (amlodipine ... Caduet is not for everyone. It is not for those with liver problems. ... FinanzNachrichten.de

Pfizer's Drug Problem: Lipitor  -  Jun 21, 2007
Pfizer has regained a tiny amount of lost prescriptions thanks to Caduet, which combines ... "Caduet appears to be gaining some traction," says Tooley, ... TheStreet.com - TheStreet.com (subscription)

Pfizer Analyst Meeting - Part 2.  -  Jan 2, 2007
Turning to Caduet, we saw strong performance for Caduet in 2006 with ... We have strong expectations for Caduet this year and a three-pronged action plan. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

DRUG CAPSULE WHAT YOU SHOULD KNOW | Article from The …  -  Dec 4, 2006
Caduet (amlodipine besylate and atorvastatin calcium) What it does: Caduet treats high blood pressure, angina and unhe... Pay-Per-View - Milwaukee Journal Sentinel - HighBeam Research

Pfizer: torcetrapib failure compounds current problems  -  Dec 5, 2006
In 2004, Pfizer launched Caduet, a combination of Lipitor and its antihypertensive Norvasc (amlodipine besylate). This cross-risk-factor therapy proved too ... Pharmaceutical Business Review

Pfizer sues Ranbaxy (folo)Ranbaxy offers to buy Merck's generics …  -  Mar 14, 2007
Pfizer is promoting Caduet before patents protecting the medicine expire. 2007 Copyright International Herald Tribune. http://www.iht.com ... Pay-Per-View - International Herald Tribune - HighBeam Research

Initial Results of Large Hypertension Study Reaffirms Norvasc's …  -  Mar 8, 2005
With Caduet, physicians have the option to offer patients the benefits of ... Caduet (amlodipine besylate/atorvastatin calcium) is a prescription drug used ... RedOrbit

YOUR HEALTH / Combination pills: Patients should weigh convenience …  -  Oct 27, 2008
Pfizer Inc's Caduet, a prescription pill that combines the blood pressure pill ... Because Caduet is often not on a health plan's preferred list of drugs, ... $2.95 - Press of Atlantic City, The - NewsBank

Ask the doctor.  -  Apr 1, 2007
A Caduet is a combination medication that contains amlodipine (norvasc) and ... Caduet is available in several combinations of doses of amlodipine and ... Free with registration - Healthy Years - AccessMyLibrary.com

STOCKWATCH Ranbaxy drops 5.5 pct on patent settlement with Pfizer …  -  Jun 19, 2008
Under the terms of the agreement, Ranbaxy will have a license to sell generic versions of Lipitor and Caduet in the United States, as of Nov. 30, 2011. ... Forbes

Ask the doctor. | Article from Healthy Years | HighBeam Research  -  Apr 1, 2007
Ask the doctor. ... find Healthy Years articles. Q My doctor recently started me on Caduet (10/20 mg). What exactly is this drug and how will it help me? Pay-Per-View - Healthy Years - HighBeam Research

Drug makers rush to fill heart-healthy lifestyle gap.(Chain Pharmacy)  -  Jan 17, 2005
Caduet is an interesting combination therapy in that it combines a calcium channel blocker, Norvasc, for treating high blood pressure and the statin Lipitor ... Pay-Per-View - Drug Store News - Factiva, from Dow Jones

Mixed Reviews for 2 of Pfizer's Top Drugs  -  Mar 9, 2005
Last year, Pfizer introduced a single-pill combination of Lipitor and Norvasc called Caduet, although Caduet's sales have been slow so far. ... New York Times

Analysis: Pfizer's Q2 disappoints  -  Jul 18, 2007
Products that did not see a price increase include Lipitor, Caduet, Lyrica, Exubera and Eraxis. But Boris said he anticipates Pfizer will apply its ... United Press International

Will Metabolic Syndrome Emerge as a Commercial Market?  -  Jun 28, 2007
Despite being the only available agent that treats multiple components of metabolic syndrome, Pfizer's Caduet has seen limited uptake. ... Genetic Engineering News - Genetic Engineering News (press release)

Antihypertensives: Generics striking at heart of the market.  -  Nov 15, 2006
Pfizer has attempted to protect amlodipine revenues by launching Caduet (amlodipine and ... With sales of Caduet reaching only $178m in the US in 2005, ... Free with registration - M2 Presswire - AccessMyLibrary.com

Pfizer Fourth-Quarter and Full-Year 2005 Financial Results Reflect …  -  Jan 19, 2006
The combined sales of these products (Inspra, Caduet, Olmetec, Macugen, Revatio, Zmax, and Lyrica) generated $284 million in fourth-quarter 2005 revenue and ... Free with registration - PR Newswire - AccessMyLibrary.com

Falling leaves: for the majority medical/surgical and specialty...  -  Nov 1, 2006
A 43% boost in spending moved Pfizer's Caduet from 12th to 6th, while Pfizer's Lipitor dropped from 4th to 7th as ad outlays were reduced by 14%. ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com

Combo drugs deliver healthy profits  -  Jan 21, 2005
Researchers at Find/SVP Health Care cite Pfizer's Caduet as another ... In doing so Caduet becomes the first drug to treat different ailments with one drug. ... DrugResearcher.com

Generics "striking at the heart of the antihypertensives market," …  -  Nov 27, 2006
Pfizer has attempted to protect amlodipine revenues by launching Caduet ... With sales of Caduet reaching only $178.0 million in the USA in 2005, ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Antidote.  -  Jun 1, 2005
Caduet merges the top cholesterol-lowering drug on the market with a commonly ... Therefore, it might be more reasonable for a doctor to turn to Caduet only ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com

Firm to combine drugs for multiple ailments  -  Feb 1, 2007
Three years ago, for example, Pfizer launched Caduet, a pill combining the New York drug giant's Norvasc for hypertension and Lipitor for cholesterol into a ... Pay-Per-View - Chicago Tribune - ProQuest Archiver

Article: Pfizer fills its dry pipeline with optimism - International...  -  Jul 18, 2006
From 2000 to 2005, Pfizer's laboratories created only a handful of new drugs, leaving the company dependent on dubious innovations like Caduet, ... Pay-Per-View - International Herald Tribune - HighBeam Research

Top Pfizer scientist expects pipeline payoffs | Article from Internati...  -  Jul 19, 2006
From 2000 to 2005, Pfizer's laboratories created only a handful of new drugs, leaving the company dependent on dubious innovations like Caduet, ... Pay-Per-View - International Herald Tribune - HighBeam Research

Press Release: Antihypertensives: Generics striking at heart of the...  -  Nov 15, 2006
Pfizer has attempted to protect amlodipine revenues by launching Caduet (amlodipine and ... With sales of Caduet reaching only $178m in the US in 2005, ... Pay-Per-View - M2 Presswire - HighBeam Research

NPS cautions GPs on use of antihypertensive-statin  -  Dec 1, 2006
Out-of-pocket costs for the patient would be lower for Caduet than with amlodopine and atorvastatin as separate medicines, the NPS said. ... Pay-Per-View - Australian Doctor - Factiva, from Dow Jones

Journals gather momentum: medical/surgical journals continued to show...  -  Apr 1, 2005
Six of Pfizer's brands made the top 25, including Caduet, a new entry that ... Caduet, a new Pfizer brand, was third, while the cholesterol reducers Lipitor ... $20.00 - Medical Marketing & Media - Alacra Store

Antidote.  -  Jun 1, 2005
Caduet merges the top cholesterol-lowering drug on the market with a commonly ... Therefore, it might be more reasonable for a doctor to turn to Caduet only ... $9.94 - Medical Marketing & Media - Alacra Store

Press Release: PFIZER INC - Interim Results. - PR Newswire UK...  -  Jul 20, 2005
Caduet continues its steady growth, up 143 percent year-to-date to $73 million. Caduet is a clinical enhancement to manage hypertensive patients with other ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research

Pfizer accused of "influencing" Canadian doctors with payment for...  -  Feb 13, 2006
Refuting the suggestion that Pfizer was trying to induce Canadian doctors into pres-cribing Caduet, Ms Letendre derided the notion of targeting 120 doctors ... $4.95 - Pharma Marketletter - ECNext

Amlodipine/atorvastatin for preventing heart disease.(Letters to the...  -  Feb 1, 2007
TO THE EDITOR: The STEPS department on amlodipine/atorvastatin (Caduet) in the March 15, 2006, issue of American Family Physician, (1) contains several ... $4.95 - American Family Physician - ECNext

US Requests Information On Pfizer's Payment to Doctors  -  Nov 9, 2005
Separately, Pfizer said it had withdrawn an application to market Caduet, a single pill combining cholesterol-lowerer Lipitor and blood pressure reducer ... Subscription - Wall Street Journal Online - Dow Jones & Company

Big Pharma 'rearranging deck chairs on the Titanic' - Mar. 21, 2007  -  Mar 21, 2007
The resulting combo, called Caduet, totaled $370 million in 2006 sales, ... "They tried to shift prescriptions to Caduet, a combo of Norvasc and Lipitor, ... CNNMoney.com

ΚυκλοφοÏ?εί στο εμπόÏ?ιο και μειώνει τους κινδÏ?νους  -  Mar 2, 2008
Ο συνδυασμός «σε ένα χάπι» κυκλοφοÏ?εί στο εμπόÏ?ιο με το όνομα Caduet. Το Caduet πεÏ?ιέχει το φάÏ?μακο amlodipine, το οποίο χÏ?ησιμοποιείται για την ... Η ΚαθημεÏ?ινή

辉瑞起诉Ranbaxy 欲延长Lipito专利期  -  Mar 27, 2008
...此外,辉瑞还就触犯å?Œæ ·ä¸“利的问题æ??交了å?¦ä¸€ä»½é’ˆå¯¹Ranbaxy的诉状,以求延长Caduetçš„ 专利æ?ƒè‡³2016å¹´7月å‰?å?Žã€‚Caduet是Lipitor和高血压è?¯ç‰©Norvasc的混å?ˆåˆ¶å“?。2007 ... 新浪网

БиотехнологиÑ? : ЛекарÑ?тво от атероÑ?клероза и гипертензии в од  -  May 17, 2005
Ð?овобранец фармацевтичеÑ?кого рынка Caduet может применÑ?тьÑ?Ñ? длÑ? одновременного ... Официальные предÑ?тавители фирмы заÑ?вили, что Caduet Ñ?влÑ?етÑ?Ñ? первым ... КоммерчеÑ?каÑ? биотехнологиÑ?

Pfizer's patented products hit the shelves in India. | Article from...  -  Apr 25, 2005
108 for 14 tablets). Pfizer has also launched another ... blockbuster drugs, Caduet, in India. Caduet, a new generation ... ... Pay-Per-View - Economic Times - HighBeam Research

New indication for docetaxel.(Products)(Brief Article) | Article from...  -  Feb 1, 2005
The combination drug Caduet (amlodipine besylate/atorvastatin calcium) is ... For more information, contact Pfizer Inc. by visiting www.caduet.com or ... Pay-Per-View - Family Practice News - HighBeam Research

Article: Sales of generic versions of Accupril halted by court.(RETAIL...  -  Apr 18, 2005
The lawsuits between Pfizer and Ranbaxy regarding Lipitor and Caduet ... ... Pfizer, Ranbaxy at it again over Caduet New Delhi, Mar 13 (PTI) Ranbaxy ... Pay-Per-View - Chain Drug Review - HighBeam Research

Viagra debuts in India at Rs 463  -  Dec 21, 2005
Caduet was launched in the global market in January 2004, and is a dual combination of Norvasc and Lipitor, and treats both high blood pressure and high ... Financial Express

New Data Show Hypertensive Patients Taking Norvasc-Based Regimen …  -  Nov 13, 2005
Norvasc is a major component of Caduet (amlodipine besylate/ atorvastatin ... Caduet was approved by the Food and Drug Administration in February 2004. ... Free with registration - PR Newswire - AccessMyLibrary.com

Medications may cause chronic pain  -  Dec 11, 2007
I am taking Micardis, Caduet, Toprol and Flomax. I am taking all of these medications and still have no relief. Your opinion would be greatly appreciated. ... $2.95 - Erie Times-News - NewsBank

Deep freeze: for medical/surgical journals, 2005 was another long,...  -  Apr 1, 2006
Lipitor, Caduet, Celebrex and Viagra were among the major products advertised by Pfizer. Forest, which ended the year unchanged in the number two spot, ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy